// App-Quantinova.ai

: European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN: structure and impact since 2009

Researchers

Presenter

  • Silke Van Koningsbruggen-Rietschel

Principal Investigators

  • Damian G. Downey

  • Lieven Dupont

  • Fiona Dunlevy

  • Veerle Bulteel

  • Kate Hayes

  • Nick Simmonds

  • Nadine Dufeu

  • Hettie M. Janssens

  • Dorota Sands

  • Paola De Carli

  • Isabelle Sermet-Gaudelus

  • Kris De Boeck

  • Tim Lee

  • Isabelle Fajac

Medical Centers

  • Cystic Fibrosis Centre, Children’s Hospital, Faculty of Medicine, University of Cologne, Cologne, Germany

  • Centre for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom

  • Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium

  • European Cystic Fibrosis Society Clinical Trials Network, Cannes, France

  • European Cystic Fibrosis Society Clinical Trials Network, University Hospital Leuven, Leuven, Belgium

  • European Cystic Fibrosis Society Clinical Trials Network, Queen's University Belfast, Belfast, United Kingdom

  • Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

  • Department of Respiratory Diseases, Lung Transplant Team, University Hospital of Marseille, Marseille, France

  • Department of Pediatrics, div. of Respiratory medicine and Allergology, ErasmusMC Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, Netherlands

  • Cystic Fibrosis Department, Institute of Mother and Child, Warsaw, Poland

  • Vaincre La Mucoviscidose, Paris, France

  • Hopital Necker Enfants Malades, INSERM U1151, Institut Necker Enfants Malades, Paris, France

  • University of Leuven, KUL, Leuven, Belgium

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • APHP Centre - Université de Paris, Paris, France

Locations

  • Germany

  • United Kingdom

  • Belgium

  • France

  • Netherlands

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Cystic Fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A